Skip to main content

ADVERTISEMENT

Adam Zybulewski, MD

The STAND Trial: How the MicroStent Attempts to Break Through Barriers in Below-the-Knee CLI
Clinical Update
05/21/2020
To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.
To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.
To understand the intent behind...
05/21/2020
Vascular Disease Management
Clinical Review
04/19/2021
Fibroids are the most common benign tumor in women of reproductive age, and the most common pelvic tumor overall in women. They arise from smooth muscle cells and fibroblasts in the myometrium.
Fibroids are the most common benign tumor in women of reproductive age, and the most common pelvic tumor overall in women. They arise from smooth muscle cells and fibroblasts in the myometrium.
Fibroids are the most common...
04/19/2021
Vascular Disease Management